CDK9 inhibitors: A promising new treatment for hematological malignancies

A new research perspective was published in Oncotarget's Volume 14 on August 7, 2023, entitled, "CDK9 INHIBITORS: a promising combination partner in the treatment of hematological malignancies."

Related Keywords

Daniel Morillo ,Danielle Ellis ,Victor Moreno , ,Gala Vega ,Hospital Fundaci ,Cancer ,Drugs ,Genes ,Hospital ,Ncology ,Research ,Ranscription ,